Oppenheimer keeps USD 325 target for Veeva Systems stock
Published on 10/15/2026 at 13:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSClinical software and analyst view
- IQVIA adopted four Veeva clinical applications as enterprise standards on October 14, 2026.
- Oppenheimer reiterated an Outperform rating and a USD 325.00 target on October 15, 2026.
- Veeva Systems stock trades at EUR 266.20 at 1:16 p.m. CEST at Lang & Schwarz on October 15, 2026.
Veeva Systems (ISIN US9224751084) is trading at EUR 266.20 at Lang & Schwarz on October 15, 2026 at 1:16 p.m. CEST. Investing.com reported on October 15, 2026 that Oppenheimer reiterated an Outperform rating and a USD 325.00 price target.
IQVIA expands clinical software reach
The latest operating catalyst came on October 14, 2026, when IQVIA selected Veeva Clinical Trial Management System, eTMF, Study Startup and Site Connect as enterprise standards across its global studies, Yahoo Finance reported. The agreement broadens Veeva's role in clinical workflows, although the report did not quantify incremental revenue.
What does the USD 325 target imply?
Oppenheimer's target places the emphasis on execution rather than a new financial result. The broker said Veeva's increased guidance reflected execution and better visibility, while business consulting remained a durable services growth driver, according to Investing.com on October 15, 2026.
Three events define the recent picture
On August 26, 2026, Veeva reported quarterly revenue of USD 927.96 million and earnings per share of USD 2.35 against a USD 2.23 consensus estimate, according to MarketBeat. On October 14, 2026, IQVIA adopted four Veeva clinical applications as standards across its studies. On October 15, 2026, Oppenheimer reiterated its Outperform rating and USD 325.00 target.
Next date is November 5
Veeva is scheduled to hold a virtual Investor Day on November 5, 2026, according to MarketBeat. The event is expected to address product adoption, artificial intelligence initiatives and financial targets.
Stock price and company scale
Veeva's latest reported second-quarter fiscal 2027 revenue was USD 927.96 million, up 17.6 percent year over year, while net income reached USD 273.43 million. The finance data profile identifies Veeva as a Technology company in Software - Application, with 7,928 full-time employees.
Veeva Systems stock was trading at EUR 266.20 at Lang & Schwarz on October 15, 2026 at 1:16 p.m. CEST. Its primary listing is on the NYSE, where the October 14, 2026 close was USD 301.63 and the 52-week range was USD 148.05 to USD 309.32.
The further course of trading is shown by the continuously updated real-time quote of Veeva Systems stock.
Veeva Systems stock at a glance
- Company: Veeva Systems Inc.
- ISIN: US9224751084
- Ticker: VEEV
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 15, 2026, 1:16 p.m. CEST): EUR 266.20
- Market capitalization: USD 48.1 billion (as of October 14, 2026)
- 52-week range: USD 148.05-309.32 (as of October 14, 2026)
- Sector / Industry: Technology / Software - Application
Market context: Market report S&P 500.
